Literature DB >> 31230581

Differential Access to Transgender Inclusive Insurance and Healthcare in the United States: Challenges to Health across the Life Course.

Matthew Bakko1, Shanna K Kattari2.   

Abstract

This commentary explores how different types of insurance (Medicare, Medicaid, state government, and private insurance) address issues of transgender-related care, and how access to transgender affirming insurance coverage and healthcare across life stages depends both on type of insurance and geographical location. We argue that the current state of transgender health insurance policy and practices are inadequate for achieving goals of continuity of care and positive health outcomes across the life course. Transgender individuals are uninsured at a higher rate than their cisgender (non-transgender) counterparts, face discrimination or refusal of care from their providers, and, if insured, experience denials of coverage from insurance companies. These ruptures in coverage can be addressed through extending insurance coverage for all treatments necessary to affirm a transgender person's gender identity, training to support transgender affirming healthcare, and research on the health needs of the transgender community across the life course.

Entities:  

Keywords:  Transgender; health insurance; health policy; inequality; life course

Mesh:

Year:  2019        PMID: 31230581     DOI: 10.1080/08959420.2019.1632681

Source DB:  PubMed          Journal:  J Aging Soc Policy        ISSN: 0895-9420


  5 in total

1.  Transition Coverage and Clarity in Self-Insured Corporate Health Insurance Benefit Plans.

Authors:  Anna Kirkland; Shauhin Talesh; Angela K Perone
Journal:  Transgend Health       Date:  2021-07-30

2.  Standards of Care for the Health of Transgender and Gender Diverse People, Version 8.

Authors:  E Coleman; A E Radix; W P Bouman; G R Brown; A L C de Vries; M B Deutsch; R Ettner; L Fraser; M Goodman; J Green; A B Hancock; T W Johnson; D H Karasic; G A Knudson; S F Leibowitz; H F L Meyer-Bahlburg; S J Monstrey; J Motmans; L Nahata; T O Nieder; S L Reisner; C Richards; L S Schechter; V Tangpricha; A C Tishelman; M A A Van Trotsenburg; S Winter; K Ducheny; N J Adams; T M Adrián; L R Allen; D Azul; H Bagga; K Başar; D S Bathory; J J Belinky; D R Berg; J U Berli; R O Bluebond-Langner; M-B Bouman; M L Bowers; P J Brassard; J Byrne; L Capitán; C J Cargill; J M Carswell; S C Chang; G Chelvakumar; T Corneil; K B Dalke; G De Cuypere; E de Vries; M Den Heijer; A H Devor; C Dhejne; A D'Marco; E K Edmiston; L Edwards-Leeper; R Ehrbar; D Ehrensaft; J Eisfeld; E Elaut; L Erickson-Schroth; J L Feldman; A D Fisher; M M Garcia; L Gijs; S E Green; B P Hall; T L D Hardy; M S Irwig; L A Jacobs; A C Janssen; K Johnson; D T Klink; B P C Kreukels; L E Kuper; E J Kvach; M A Malouf; R Massey; T Mazur; C McLachlan; S D Morrison; S W Mosser; P M Neira; U Nygren; J M Oates; J Obedin-Maliver; G Pagkalos; J Patton; N Phanuphak; K Rachlin; T Reed; G N Rider; J Ristori; S Robbins-Cherry; S A Roberts; K A Rodriguez-Wallberg; S M Rosenthal; K Sabir; J D Safer; A I Scheim; L J Seal; T J Sehoole; K Spencer; C St Amand; T D Steensma; J F Strang; G B Taylor; K Tilleman; G G T'Sjoen; L N Vala; N M Van Mello; J F Veale; J A Vencill; B Vincent; L M Wesp; M A West; J Arcelus
Journal:  Int J Transgend Health       Date:  2022-09-06

3.  Ensuring health equity for sexual and/or gender minority individuals.

Authors:  Juan D Salcedo-Betancourt; Samira S Farouk; Yuvaram N V Reddy
Journal:  Nat Rev Nephrol       Date:  2022-06       Impact factor: 42.439

Review 4.  Telehealth in Trans and Gender Diverse Communities: the Impact of COVID-19.

Authors:  Laura J Mintz; Braveheart Gillani; Scott E Moore
Journal:  Curr Obstet Gynecol Rep       Date:  2022-04-19

5.  "I just felt supported": Transgender and non-binary patient perspectives on receiving transition-related healthcare in family planning clinics.

Authors:  Natalie Ingraham; Lindsey Fox; Andres Leon Gonzalez; Aerin Riegelsberger
Journal:  PLoS One       Date:  2022-07-21       Impact factor: 3.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.